Precision Timing of Beta-Lactam Administration in Very Low Birth Weight Infants with Suspected Sepsis: A Multi-National Cohort Study
DOI:
https://doi.org/10.52783/jns.v14.1897Keywords:
very low birth weight infants, neonatal sepsis, beta-lactam antibiotics, antibiotic timing, mortality, antimicrobial stewardshipAbstract
Background: Timely administration of antibiotics is critical in the management of sepsis, but evidence regarding optimal timing of beta-lactam administration in very low birth weight (VLBW) infants remains limited. This study investigated the association between precision timing of beta-lactam administration and clinical outcomes in VLBW infants with suspected sepsis.
Methods: We conducted a retrospective multi-national cohort study across 4 neonatal intensive care units in 4 countries from January 2021 to December 2023. VLBW infants (birth weight <1500 g) with clinically suspected sepsis who received beta-lactam antibiotics were included. The primary outcome was all-cause 30-day mortality. Secondary outcomes included duration of mechanical ventilation, length of hospital stay, and development of antibiotic-resistant infections. Time-to-antibiotic was defined as the interval between clinical recognition of sepsis and administration of the first beta-lactam dose.
Results: Among 58 VLBW infants with suspected sepsis (median gestational age 27.3 weeks [IQR 25.6-29.1], median birth weight 980 g [IQR 780-1250]), 14 (24.1%) had culture-confirmed sepsis. Median time-to-antibiotic was 65 minutes (IQR 42-95). Each hour delay in beta-lactam administration was associated with an increased risk of 30-day mortality (adjusted hazard ratio [aHR] 1.16, 95% CI 1.02-1.32, p=0.024), particularly in infants with culture-confirmed sepsis (aHR 1.28, 95% CI 1.05-1.55, p=0.012). Administration within 60 minutes was achieved in 46.6% (n=27) of cases and was associated with lower mortality compared to administration after 60 minutes (7.4% vs. 16.1%, p=0.042). Unit-level barriers to timely administration included delays in recognition, central line access difficulties, and medication preparation processes.
Conclusions: Delayed beta-lactam administration in VLBW infants with suspected sepsis is associated with increased mortality, with each hour of delay conferring additional risk. Achieving administration within 60 minutes of sepsis recognition may improve outcomes in this vulnerable population. Quality improvement initiatives targeting identified barriers to timely antibiotic delivery are warranted.
Downloads
Metrics
References
Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015;314(10):1039-1051.
Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390(10104):1770-1780.
Cailes B, Kortsalioudaki C, Buttery J, et al. Epidemiology of UK neonatal infections: the neonIN infection surveillance network. Arch Dis Child Fetal Neonatal Ed. 2018;103(6):F547-F553.
Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6(3):223-230.
Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr. 2015;61(1):1-13.
Ku LC, Boggess KA, Cohen-Wolkowiez M. Bacterial meningitis in infants. Clin Perinatol. 2015;42(1):29-45.
Tzialla C, Borghesi A, Serra G, et al. Antimicrobial therapy in neonatal intensive care unit. Ital J Pediatr. 2015;41:27.
Flannery DD, Ross RK, Mukhopadhyay S, et al. Temporal trends and center variation in early antibiotic use among premature infants. JAMA Netw Open. 2018;1(1):e180164.
Cantey JB, Patel SJ. Antimicrobial stewardship in the NICU. Infect Dis Clin North Am. 2014;28(2):247-261.
Pacifici GM. Clinical pharmacology of gentamicin in neonates: regimen, toxicology and pharmacokinetics. Med Express. 2015;2(5):1-10.
Germovsek E, Barker CI, Sharland M. What do I need to know about aminoglycoside antibiotics? Arch Dis Child Educ Pract Ed. 2017;102(2):89-93.
Allegaert K, Smits A, van den Anker JN. Physiologically-based pharmacokinetic modeling in pediatric drug development: a clinician's request for a more integrated approach. J Biomed Biotechnol. 2012;2012:103763.
Rhodin MM, Anderson BJ, Peters AM, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol. 2009;24(1):67-76.
Roberts JA, Abdul-Aziz MH, Lipman J, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014;14(6):498-509.
Ambrose PG, Bhavnani SM, Rubino CM, et al. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore. Clin Infect Dis. 2007;44(1):79-86.
Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-1596.
Cies JJ, Moore WS, Chopra A, et al. Population pharmacokinetics of piperacillin/tazobactam in critically ill young children. Pediatr Infect Dis J. 2017;36(3):223-229.
van den Anker JN, Allegaert K. Pharmacokinetics of antibiotics in preterm infants: the effect of gestational age. Curr Pharm Des. 2017;23(38):5760-5765.
Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235-2244.
Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med. 2020;21(2):e52-e106.
Wynn JL, Wong HR. Pathophysiology and treatment of septic shock in neonates. Clin Perinatol. 2010;37(2):439-479.
Thampi N, Shah PS, Nelson S, et al. Improving timeliness of antibiotic administration using a provider and pharmacist intervention in infants admitted to a neonatal intensive care unit with presumed sepsis. Hosp Pediatr. 2019;9(6):451-459.
Dukhovny D, Buus-Frank ME, Edwards EM, et al. A collaborative multicenter QI initiative to improve antibiotic stewardship in newborns. Pediatrics. 2019;144(6):e20190589.
Vasiljevic B, Antonovic O, Maglajic-Djukic S, et al. Early imaging diagnostics for sepsis in newborns. Med Pregl. 2013;66 Suppl 1:31-37.
Nakamura T, Hatanaka D, Yoshikawa T, et al. Neonatal risk factors predictive of neonatal sepsis: A systematic review and meta-analysis. Front Pediatr. 2022;10:908639.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-349.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194.
Wynn JL, Wong HR, Shanley TP, et al. Time for a neonatal-specific consensus definition for sepsis. Pediatr Crit Care Med. 2014;15(6):523-528.
Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.
Gillam MH, Pratt NL, Inacio MCS, et al. Data quality statements in observational studies. Int J Popul Data Sci. 2018;3(1):438.
Wynn JL, Polin RA. A neonatal sequential organ failure assessment score predicts mortality to late-onset sepsis in preterm very low birth weight infants. Pediatr Res. 2020;88(1):85-90.
Johnston ANB, Park J, Doi SA, et al. Effect of immediate administration of antibiotics in patients with sepsis in tertiary care: a systematic review and meta-analysis. Clin Ther. 2017;39(1):190-202.e6.
Puopolo KM, Benitz WE, Zaoutis TE, et al. Management of neonates born at ≥35 0/7 weeks' gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142(6):e20182894.
Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165-228.
Schoenfeld DA, Bernard GR; ARDS Network. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002;30(8):1772-1777.
Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018;44(6):925-928.
Williams R. Analyzing rare events with logistic regression. Sociol Methods Res. 2017;46(2):155-189.
White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377-399.
Kumar A, Ellis P, Arabi Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136(5):1237-1248.
Weiss SL, Fitzgerald JC, Balamuth F, et al. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit Care Med. 2014;42(11):2409-2417.
Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749-1755.
Pruitt CM, Hains DS, Billings RG, et al. Association between timing of antibiotics and outcomes in children with bacterial meningitis. Pediatr Emerg Care. 2018;34(6):390-396.
Schlapbach LJ, Straney L, Alexander J, et al. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: a multicentre retrospective cohort study. Lancet Infect Dis. 2015;15(1):46-54.
Zaidi AKM, Huskins WC, Thaver D, et al. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365(9465):1175-1188.
Evans IVR, Phillips GS, Alpern ER, et al. Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis. JAMA. 2018;320(4):358-367.
Seymour CW, Kahn JM, Martin-Gill C, et al. Delays from first medical contact to antibiotic administration for sepsis. Crit Care Med. 2017;45(5):759-765.
Manaktala S, Claypool SR. Evaluating the impact of a computerized surveillance algorithm and decision support system on sepsis mortality. J Am Med Inform Assoc. 2017;24(1):88-95.
Evans ME, Murray CK, Holmes-Maybank K, et al. Relative costs of antibiotic resistance in healthcare environments. Antimicrob Resist Infect Control. 2022;11(1):36.
Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1-10.
Leroux S, Zhao W, Bétrémieux P, et al. Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey. Arch Dis Child. 2015;100(4):394-398.
Committee on Infectious Diseases, American Academy of Pediatrics. Red Book: 2021-2024 Report of the Committee on Infectious Diseases. 32nd ed. American Academy of Pediatrics; 2021.
Schulman J, Dimand RJ, Lee HC, et al. Neonatal intensive care unit antibiotic use. Pediatrics. 2015;135(5):826-833.
Zaidi AKM, Thaver D, Ali SA, et al. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J. 2009;28(1 Suppl):S10-S18.
Mitha A, Foix-L'Hélias L, Arnaud C, et al. Neonatal infection and 5-year neurodevelopmental outcome of very preterm infants. Pediatrics. 2013;132(2):e372-e380.
Hooven TA, Polin RA. Healthcare-associated infections in the hospitalized neonate: a review. Early Hum Dev. 2014;90(Suppl 1):S4-S6.
Lingscheid T, Tobudic S, Fellinger M, et al. In vitro pharmacodynamics of piperacillin/tazobactam against Enterobacteriaceae analyzed by probabilistic and mechanistic modelling. J Antimicrob Chemother. 2020;75(9):2625-2633.
Benitz WE, Han MY, Madan A, et al. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998;102(4):E41.
Kuzniewicz MW, Puopolo KM, Fischer A, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171(4):365-371.
Lu C, Liu Q, Yuan H, et al. Implementation of the Smart Use of Antibiotics Program to reduce unnecessary antibiotic use in a neonatal intensive care unit: a prospective interrupted time-series study in a developing country. Crit Care Med. 2019;47(1):e1-e7.
Coggins SA, Wynn JL, Weitkamp JH. Short-term and long-term outcomes of preterm infants with acute severe hypernatremia. Birth Defects Res. 2019;111(5):277-285.
Ting JY, Roberts A, Sherlock R, et al. Duration of initial empirical antibiotic therapy and outcomes in very low birth weight infants. Pediatrics. 2019;143(3):e20182286.
Manzoni P, De Luca D, Stronati M, et al. Prevention of nosocomial infections in neonatal intensive care units. Am J Perinatol. 2013;30(2):81-88.
Cotten CM, McDonald S, Stoll B, et al. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics. 2006;118(2):717-722.
Ng PC, Lam HS. Biomarkers for late-onset neonatal sepsis: cytokines and beyond. Clin Perinatol. 2010;37(3):599-610.
van Donge T, Pfister M, Bielicki J, et al. Quantitative analysis of gentamicin exposure in neonates and infants calls into question its current dosing recommendations. Antimicrob Agents Chemother. 2018;62(4):e02004-17.
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-377.
Liang LD, Kotadia N, English L, et al. Predictors of mortality in neonates and infants hospitalized with sepsis or serious infections in developing countries: a systematic review. Front Pediatr. 2018;6:277.
Cotten CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123(1):58-66.
Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014;40(1):32-40.
Johnson J, Quach C. Outbreaks in the neonatal ICU: a review of the literature. Curr Opin Infect Dis. 2017;30(4):395-403.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
